The high need for trials assessing functional outcome after stroke rather than stroke prevention with GLP-1 agonists and DPP-4 inhibitors by Vladimer Darsalia, Martin Larsson, Thomas Klein, Cesare Patrone

Get full text

Dipeptidyl Peptidase-4 Inhibitors for the Potential Treatment of Brain Disorders; A Mini-Review With Special Focus on Linagliptin and Stroke by Vladimer Darsalia, Odd Erik Johansen, Grazyna Lietzau, Thomas Nyström, Thomas Klein, Cesare Patrone

Get full text

The SGLT2 inhibitor Empagliflozin promotes post-stroke functional recovery in diabetic mice by Ellen Vercalsteren, Dimitra Karampatsi, Carolina Buizza, Thomas Nyström, Thomas Klein, Gesine Paul, Cesare Patrone, Vladimer Darsalia

Get full text

The effect of DPP-4 inhibition to improve functional outcome after stroke is mediated by the SDF-1α/CXCR4 pathway by Fausto Chiazza, Harald Tammen, Hiranya Pintana, Grazyna Lietzau, Massimo Collino, Thomas Nyström, Thomas Klein, Vladimer Darsalia, Cesare Patrone

Get full text

Exendin-4 reduces ischemic brain injury in normal and aged type 2 diabetic mice and promotes microglial M2 polarization. by Vladimer Darsalia, Sansan Hua, Martin Larsson, Carina Mallard, David Nathanson, Thomas Nyström, Åke Sjöholm, Maria E Johansson, Cesare Patrone

Get full text

Estimated glucose disposal rate and risk of stroke and mortality in type 2 diabetes: a nationwide cohort study by Alexander Zabala, Vladimer Darsalia, Marcus Lind, Ann-Marie Svensson, Stefan Franzén, Björn Eliasson, Cesare Patrone, Magnus Jonsson, Thomas Nyström

Get full text

The Pre-Stroke Induction and Normalization of Insulin Resistance Respectively Worsens and Improves Functional Recovery by Ellen Vercalsteren, Dimitra Karampatsi, Doortje Dekens, Aikaterini Letsiou, Alexander Zabala, Mihaela Romanitan, Thomas Klein, Thomas Nyström, Vladimer Darsalia, Cesare Patrone

Get full text